Results from the world’s largest prospective artificial intelligence study revealed the system could significantly benefit breast cancer screening programs.
The new atrial shunt from Alleviant Medical was designed to treat heart failure without leaving a permanent implant behind. The FDA granted the technology its breakthrough device designation and approved additional research.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
Researchers think their findings, which were presented at ESC Congress 2023 and published in the New England Journal of Medicine, could "change the nature of the conversation about the role of obesity in HFpEF."
Serious discrepancies between preliminary imaging reads and final radiology reports are at risk of accumulating when the prelims are rendered during overnight hours.
COVID-19 opened the eyes of many cardiology researchers that infections may promote inflammation in atherosclerotic plaques, leading to cardiac events.
